Publications

Proposal for a revised definition of dilated cardiomyopathy, hypokinetic non-dilated cardiomyopathy, and its implications for clinical practice: a position statement of the ESC working group on myocardial and pericardial diseases. Pinto, Yigal M.; Elliott, Perry M.; Arbustini, Eloisa; Adler, Yehuda; Anastasakis, Aris; Böhm, Michael; Duboc, Denis; Gimeno, Juan; de Groote, Pascal; Imazio, Massimo; Heymans, Stephane; Klingel, Karin; Komajda, Michel; Limongelli, Giuseppe; Linhart, Ales; Mogensen, Jens; Moon, James; Pieper, Petronella G.; Seferovic, Petar M.; Schueler, Stephan; Zamorano, Jose L.; Caforio, Alida L. P.; Charron, Philippe. European Heart Journal. 2016; : . doi:10.1093/eurheartj/ehv727
    Article
    Activity and safety of oral etoposide in pretreated patients with metastatic or recurrent thymic epithelial tumors (TET): A single-institution experience. Bluthgen, M. V.; Boutros, C.; Fayard, F.; Remon, J.; Planchard, D.; Besse, B.. Lung Cancer. 2016; 111-6: p.111-6. doi:10.1016/j.lungcan.2016.06.020 10.1016/j.lungcan.2016.06.020. Epub 2016 Jul 1.

    Article
    Critical care ultrasonography in acute respiratory failure. Vignon, Philippe; Repessé, Xavier; Vieillard-Baron, Antoine; Maury, Eric. Critical Care (London, England). 2016; 20: p.228. doi:10.1186/s13054-016-1400-8
    Article
    Patients aged over 75 years enrolled in Phase I clinical trials: the Gustave Roussy experience. Helissey, C.; Biondani, P.; Roquet, F.; Lanoy, E.; Mir, O.; Varga, A.; Massard, C.; Gazzah, A.; Ribrag, V.; Bahleda, R.; Postel-Vinay, S.; Angevin, E.; Deutsch, E.; Soria, J. C.; Hollebecque, A.. Int J Cancer. 2016; 875-80: p.875-80. doi:10.1002/ijc.29849 10.1002/ijc.29849. Epub 2015 Oct 13.

    Article
    Rituximab and dose-dense chemotherapy for adults with Burkitt's lymphoma: a randomised, controlled, open-label, phase 3 trial. Ribrag, V.; Koscielny, S.; Bosq, J.; Leguay, T.; Casasnovas, O.; Fornecker, L. M.; Recher, C.; Ghesquieres, H.; Morschhauser, F.; Girault, S.; Le Gouill, S.; Ojeda-Uribe, M.; Mariette, C.; Cornillon, J.; Cartron, G.; Verge, V.; Chassagne-Clement, C.; Dombret, H.; Coiffier, B.; Lamy, T.; Tilly, H.; Salles, G.. Lancet. 2016; 2402-11: p.2402-11. doi:10.1016/S0140-6736(15)01317-3 10.1016/S0140-6736(15)01317-3. Epub 2016 Apr 11.

    Article
    Achats compulsifs. Brahim, N.; Duroy, D.; Lejoyeux, M.. In: Reynaud, M.; Karila, L; Aubin, H.J.; Benyamina, A.. Traité d'addictologie (2° Éd.). Paris: Lavoisier Médecine Sciences; 2016. p.p.814-817.
      Book section
      Sexology in Portugal: Narratives by Portuguese Sexologists. Alarcão, Violeta; Beato, Ana; Almeida, Joana; Machado, Fernando Luís; Giami, Alain. The Journal of Sex Research. 2016; 1179-1192: p.1179-1192. doi:10.1080/00224499.2015.1104286
        Article
        Standardized evaluation of tumor-infiltrating lymphocytes in breast cancer: results of the ring studies of the international immuno-oncology biomarker working group. Denkert, C.; Wienert, S.; Poterie, A.; Loibl, S.; Budczies, J.; Badve, S.; Bago-Horvath, Z.; Bane, A.; Bedri, S.; Brock, J.; Chmielik, E.; Christgen, M.; Colpaert, C.; Demaria, S.; Van den Eynden, G.; Floris, G.; Fox, S. B.; Gao, D.; Ingold Heppner, B.; Kim, S. R.; Kos, Z.; Kreipe, H. H.; Lakhani, S. R.; Penault-Llorca, F.; Pruneri, G.; Radosevic-Robin, N.; Rimm, D. L.; Schnitt, S. J.; Sinn, B. V.; Sinn, P.; Sirtaine, N.; O'Toole, S. A.; Viale, G.; Van de Vijver, K.; de Wind, R.; von Minckwitz, G.; Klauschen, F.; Untch, M.; Fasching, P. A.; Reimer, T.; Willard-Gallo, K.; Michiels, S.; Loi, S.; Salgado, R.. Mod Pathol. 2016; 1155-64: p.1155-64. doi:10.1038/modpathol.2016.109 10.1038/modpathol.2016.109. Epub 2016 Jul 1.

        Article
        [Benefits and usability of a pharmaceutical record in medical practice. A survey of hospital doctors and pharmacists (MATRIX study)]. Schuers, M.; Timsit, M.; Gillibert, A.; Fred, A.; Griffon, N.; Bénichou, J.; Darmoni, S. J.; Staccini, P.. Revue D'epidemiologie Et De Sante Publique. 2016; 64: p.229-236. doi:10.1016/j.respe.2016.05.001
        Article
        Progression-free survival as surrogate end point for overall survival in clinical trials of HER2-targeted agents in HER2-positive metastatic breast cancer. Michiels, S.; Pugliano, L.; Marguet, S.; Grun, D.; Barinoff, J.; Cameron, D.; Cobleigh, M.; Di Leo, A.; Johnston, S.; Gasparini, G.; Kaufman, B.; Marty, M.; Nekljudova, V.; Paluch-Shimon, S.; Penault-Llorca, F.; Slamon, D.; Vogel, C.; von Minckwitz, G.; Buyse, M.; Piccart, M.. Ann Oncol. 2016; 1029-34: p.1029-34. doi:10.1093/annonc/mdw132 10.1093/annonc/mdw132. Epub 2016 Mar 8.

        Article